IDARUBICIN HYDROCHLORIDE

LOE Approaching

idarubicin hydrochloride

Pfizer
NDAINTRAVENOUSSOLUTION
Approved
Feb 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100

Mechanism of Action

DNA, inhibiting nucleic acid synthesis, inhibiting topoisomerase II activity, and producing DNA-damaging free radicals.

Company
Pfizer
Pfizer
NEW YORK, NY
593 open jobs
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers